GLUE R&D Expenses
Monte Rosa Therapeutics Inc · R&D Expenses
GLUE R&D Expenses
Latest reported$47.96Mperiod ending
GLUE Quarterly R&D Expenses ($3.82M → $47.96M)
Quarterly R&D Expenses
High-resolution chart · PNG
GLUE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 47,964,000 | |
| 44,069,000 | |
| 41,979,000 | |
| 36,678,000 | |
| 30,653,000 | |
| 32,190,000 | |
| 38,866,000 | |
| 27,616,000 | |
| 25,995,000 | |
| 25,129,000 | |
| 27,135,000 | |
| 28,306,000 | |
| 29,076,000 | |
| 26,755,000 | |
| 24,868,000 | |
| 21,342,000 | |
| 20,936,000 | |
| 17,915,000 | |
| 18,130,000 | |
| 15,115,000 | |
| 14,637,000 | |
| 9,273,000 | |
| 9,863,000 | |
| 5,472,000 | |
| 4,855,000 | |
| 3,815,000 |